Around 1 in 5 people diagnosed with cancer in the UK take part in a clinical trial.
A study looking at finding pancreatic cancer early (UK-EDI)
This study is looking at different ways to try and find early signs of pancreatic cancer.
It is open to people who are at least 50 years old and have been recently diagnosed with type 2 diabetes.
Cancer Research UK supports this study.
More about this trial
For most people a diagnosis of
It is important to know who has type 3c diabetes and who has type 2 diabetes. At the moment there are no tests or ways to find this out. By finding a way to tell the difference between type 2 and type 3c diabetes doctors might be able to detect the early signs of pancreatic cancer.
In this study researchers want to use blood samples and questionnaires to try and find a way to tell type 3c diabetes from type 2 diabetes.
The aims of this study are to:
- develop ways to tell type 3c diabetes from type 2 diabetes
- identify early signs of pancreatic cancer
You won’t get any benefit from taking part in this study. The researchers hope that the information gained from this study might help people in the future.
Who can enter
The following bullet points list the entry conditions for this study. Talk to your doctor or the study team if you are unsure about any of these. They will be able to advise you.
Who can take part
You may be able to join this study if you are at least 50 years old and have been diagnosed with diabetes within 6 months of joining the study.
Who can’t take part
You cannot join this study if any of these apply. You:
The team need 2,500 people to join the study.
You give blood samples and fill in questionnaires when you join the study and then every 6 months to 2 years.
You see a member of the study team at a local clinic every 6 months for 2 years. The first visit takes about an hour all the others take about 30 minutes.
There are no side effects if you take part in the study.
How to join a clinical trial
Professor Eithne Costell
Cancer Research UK
University of Liverpool